Objective: To investigate U. parvum (previously Ureaplasma urealyticum biovar 1) and U. urealyticum (previously Ureaplasma urealyticum biovar 2) and their subty
<正>ENSURING INFORMED CONSENT from patients and experimental subjects is today considered normal clinical practice and an essential part of biomedical research